Menu

Arcturus Therapeutics Holdings Inc. ARCT

Full chart Compare
Set alert

Price alert · ARCT

All alert types
9.31 USD -0.08 (-0.85%)

At closeNov 12, 2026, 4:31 AM EST

9.39 +0.08 +0.86%

Pre-market · Nov 12, 4:31 AM ET

9.14 Day range 9.67
5.50 52-week range 17.96
YTD
+51.88%
1 year
+7.38%

ARCT revenue history

Revenue is income from the company’s ordinary business activities.

82,031,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2011: 0USDFY 2012: 0USDFY 2013: 0USDFY 2014: 0USDFY 2015: 6,138,000USDFY 2016: 20,382,000USDFY 2017: 12,998,000USDFY 2018: 15,753,000USDFY 2019: 20,789,000USDFY 2020: 9,539,000USDFY 2021: 12,359,000USDFY 2022: 205,999,000USDFY 2023: 166,799,000USDFY 2024: 152,310,000USDFY 2025: 82,031,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3182,031,000-70,279,000-46.14%
FY 20242024-12-31152,310,000-14,489,000-8.69%
FY 20232023-12-31166,799,000-39,200,000-19.03%
FY 20222022-12-31205,999,000193,640,0001566.79%
FY 20212021-12-3112,359,0002,820,00029.56%
FY 20202020-12-319,539,000-11,250,000-54.12%
FY 20192019-12-3120,789,0005,036,00031.97%
FY 20182018-12-3115,753,0002,755,00021.20%
FY 20172017-12-3112,998,000-7,384,000-36.23%
FY 20162016-12-3120,382,00014,244,000232.06%
FY 20152015-12-316,138,0006,138,000Not meaningful
FY 20142014-12-3100Not meaningful
FY 20132013-12-3100Not meaningful
FY 20122012-12-3100Not meaningful
FY 20112011-12-310Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-08-09T06:01:57.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.